Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Czechia

Institute of Hematology and Blood Transfusion, Prague

Proton Therapy Center Czech, Prague